← All organizations

Tmunity Therapeutics

For profitWebsite ↗

Also known as: Tmunity Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 19, 2023

Acquired by Kite Pharma, Inc. → Gilead Sciences on Dec 20, 2022

Timeline

2010s

Jun 1, 2015
Tmunity Therapeutics— Founded
Oct 3, 2017
Gilead Sciences— Now

2020s

Dec 20, 2022
Kite Pharma, Inc.— Acquired By

Drugs by trial phase (7 distinct, 5 trials)

Phase 2 (1 own, 0 via acquisition)

tmpsma-02

Phase 1 (6 own, 0 via acquisition)

Indications

Studied for

Recent trials (5)

NCT05168423CollaboratorPhase 1Mar 19, 2023
NCT05650749CollaboratorPhase 1Jan 30, 2023
NCT05489991Lead sponsorPhase 1/Phase 2Sep 6, 2022
NCT04227275Lead sponsorPhase 1Nov 22, 2019
NCT04025216Lead sponsorPhase 1Aug 1, 2019

Details

Founded: Philadelphia, PA, US Jun 1, 2015
Last known activity: Mar 19, 2023